البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
CHLORPHENIRAMINE MALEATE
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
R06AB
TABLETS
CHLORPHENIRAMINE MALEATE 2 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
SUBSTITUTED ALKYLAMINES
Symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated urticaria and angioedema, amelioration of allergic reactions to blood or plasma, dermatographism, adjunctive therapy in anaplylactic reactions.
2014-07-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only AHISTON ® TABLETS COMPOSITION Each tablet contains: Chlorpheniramine maleate 2 mg For information regarding inactive ingredients and allergens, see section 2 “Important information about some of the ingredients of the medicine” and section 6 “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. The medicine is not intended for children under the age of 6 years. 1. WHAT IS THE MEDICINE INTENDED FOR? Relieving symptoms of seasonal allergy, such as: runny nose and conjunctivitis, allergic skin reactions and other allergic reactions. THERAPEUTIC CLASS Antihistamine 2. BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE IF: • There is a known sensitivity to chlorpheniramine maleate, to any of the other ingredients of the medicine or to other antihistamines (see section 6 "Additional information"). • You are taking antidepressants of the monoamine oxidase inhibitors group (MAO inhibitors) or within 14 days of discontinuing use of these medicines. • You are taking other medicines that contain antihistamines, including preparations for relieving cold and cough. SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE BEFORE TREATMENT WITH AHISTON, INFORM YOUR DOCTOR if you have had in the past or currently have: • High blood pressure • Heart problems • Epilepsy • Elevated intraocular pressure (glaucoma) • Prostate problems • Liver disease • Kidney disease • Bronchitis • Asthma • Bronchiectasis, widened bronchi • Chronic lung disease (difficulty breathing and cough that does not go away) DRUG INTERACTIONS IF YOU ARE T اقرأ الوثيقة كاملة
Ahiston-2mg-tablets-LC+KL-Notification-SPC-12-2021 SUMMARYOF PRODUCT CHARACTERSITICS 1. NAME OF THE MEDICINAL PRODUCT AHISTON Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Chlorpheniramine maleate 2 mg Excipients with known effect: Lactose content: 118 mg/tablet. Sodium content: 0.14-0.21 mg/tablet. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Yellow, round tablet, scored in half on one side, engraved "IKA" on the other. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated urticaria and angioedema, amelioration of allergic reactions to blood or plasma, dermatographism, adjunctive therapy in anaphylactic reactions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral Administration only. Do no exceed the stated dose or frequency of dosing. It is recommended that this medicine be taken with or after food. The adult dosage is 1-2 tablets, 3-4 times daily, as needed. The dosage in children 6-12 years of age is 1/2-1 tablet 3-4 times daily, as needed. Not recommended for children under 6. 4.3 CONTRAINDICATIONS Chlorphenamine is contra-indicated in patients who are hypersensitive to antihistamines or to any of the other ingredients. The anticholinergic properties of chlorphenamine are intensified by monoamine oxidase inhibitors (MAOIs). Chlorphenamine is therefore contra-indicated in patients who have been treated with MAOIs within the last fourteen days. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Chlorphenamine in common with other drugs having anticholinergic effects, should be used with caution in epilepsy, raised intra-ocular pressure including glaucoma, prostatic hypertrophy; severe hypertension or cardiovascular disease; bronchitis, bronchiectasis and asthma; hepatic impairment; renal impairment Children and the elderly are more likely to experience the neurological anticholinergic effects and paradoxical excitation (eg. increased e اقرأ الوثيقة كاملة